Back to Search Start Over

Clinical and genetic description of patients with prenatally identified cardiac tumors.

Authors :
Mariscal-Mendizábal LF
Sevilla-Montoya R
Martínez-García AJ
Alaez-Verson C
Monroy-Muñoz IE
Pérez-Durán J
Cerón-Albarrán JA
Carrillo-Sánchez K
Molina-Garay C
Flores-Lagunes LL
Jimenez-Olivares M
Aguinaga-Ríos M
Source :
Prenatal diagnosis [Prenat Diagn] 2019 Oct; Vol. 39 (11), pp. 998-1004. Date of Electronic Publication: 2019 Jul 23.
Publication Year :
2019

Abstract

Objective: Rhabdomyomas are the most common type of prenatal cardiac tumors. When isolated, 50% to 70% are related to the tuberous sclerosis complex (TSC). The aim of this study was to reinforce the importance of additional clinical data in patients with prenatal heart tumors.<br />Methods: From 2010 to 2017, 10 prenatally detected cardiac tumors were referred to the Genetics Department, and a complete family history was taken. Postnatal echocardiographic and full clinical evaluation were completed. Next generation sequencing (NGS) of the TSC1 and TSC2 genes was performed.<br />Results: The 10 cases were postnatally confirmed as rhabdomyomas. Four de novo and four family cases were detected, and only one patient was previously aware of the TSC diagnosis. Molecular analysis by NGS was performed in four patients with three TSC2 mutations, two of which were previously reported and one not.<br />Discussion: Prenatal cardiac tumors are associated with TSC in 60% of cases. Prenatal diagnosis of cardiac tumors permits a further analysis of family members using the fetus as a clue for familial disease diagnosis.<br /> (© 2019 John Wiley & Sons, Ltd.)

Details

Language :
English
ISSN :
1097-0223
Volume :
39
Issue :
11
Database :
MEDLINE
Journal :
Prenatal diagnosis
Publication Type :
Academic Journal
Accession number :
31291687
Full Text :
https://doi.org/10.1002/pd.5521